Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases
- 29 February 1996
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 24 (2), 177-184
- https://doi.org/10.1016/s0168-8278(96)80027-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Significance of Serum Type-IV Collagen Levels in Various Liver Diseases Measurement with a One-Step Sandwich Enzyme Immunoassay Using Monoclonal Antibodies with Specificity for Pepsin-Solubilized Type-IV CollagenScandinavian Journal of Gastroenterology, 1992
- Matrix Degradation in the LiverSeminars in Liver Disease, 1990
- Liver collagen mRNA and serum amino-terminal peptide of type III procollagen (PIIINP) levels in patients with alcoholic liver diseaseJournal of Hepatology, 1989
- Clinical Significance of Serum Type-III Procollagen Arninopropeptide in Hepatitis B Virus-Related Liver DiseasesScandinavian Journal of Gastroenterology, 1989
- Therapeutic strategies for hepatic fibrosisHepatology, 1988
- Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long‐term follow‐up studyLiver International, 1987
- Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitisGastroenterology, 1986
- Serum concentration of the aminoterminal procollagen type III peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosisJournal of Hepatology, 1986
- A Radioimmunoassay Procedure for Type Iii Procollagen: Its Use in the Detection of Hepatic FibrosisHepatology, 1985
- The N-Terminal Propeptide of Collagen Type III in Serum Reflects Activity and Degree of Fibrosis in Patients with Chronic Liver Disease†Hepatology, 1984